Cargando…
Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts
BACKGROUND: The limited proliferative ability of hepatocytes is a major limitation to meet their demand for cell-based therapy, bio-artificial liver device, and drug tests. One strategy is to amplify cells at the hepatoblast (HB) stage. However, expansion of HBs with their bipotency preserved is cha...
Autores principales: | Pan, Tingcai, Chen, Yan, Zhuang, Yuanqi, Yang, Fan, Xu, Yingying, Tao, Jiawang, You, Kai, Wang, Ning, Wu, Yuhang, Lin, Xianhua, Wu, Feima, Liu, Yanli, Li, Yingrui, Wang, Guodong, Li, Yin-xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888929/ https://www.ncbi.nlm.nih.gov/pubmed/31791391 http://dx.doi.org/10.1186/s13287-019-1463-y |
Ejemplares similares
-
Robust expansion and functional maturation of human hepatoblasts by chemical strategy
por: Pan, Tingcai, et al.
Publicado: (2021) -
Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression
por: Xu, Yingying, et al.
Publicado: (2021) -
Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)
por: Xu, Yingying, et al.
Publicado: (2020) -
SAA1/TLR2 axis directs chemotactic migration of hepatic stellate cells responding to injury
por: Getachew, Anteneh, et al.
Publicado: (2021) -
Inhibition of Hedgehog Delays Liver Regeneration through Disrupting the Cell Cycle
por: Tao, Jiawang, et al.
Publicado: (2022)